Unraveling the mystery of von Willebrand factor

Journal of Thrombosis and Haemostasis

Volumn 4, Issue 3, 2006, Pages 489-495

  Bouma, Bonno N ^a,b   Van Mourik, J A ^c  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c Department of Blood Coagulation ^*  (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8 ANTIBODY; BLOOD CLOTTING FACTOR 8 CONCENTRATE; OLIGOMER; RISTOCETIN; VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ARTICLE; AUTOSOMAL DOMINANT DISORDER; BLEEDING TIME; BLOOD CLOTTING; COLUMN CHROMATOGRAPHY; COMPLEX FORMATION; DISSOCIATION; HUMAN; IONIC STRENGTH; NONHUMAN; PENETRANCE; PLASMA TRANSFUSION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; VON WILLEBRAND DISEASE; WORKSHOP;

ANIMALS; BLOOD COAGULATION; BLOOD PLATELETS; FACTOR VIII; HISTORY, 20TH CENTURY; HUMANS; PLATELET AGGREGATION; PROTEIN CONFORMATION; VON WILLEBRAND DISEASE; VON WILLEBRAND FACTOR;

EID: 33645964612     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2006.01813.x     Document Type: Article

References (42)

1. van Mourik JA. Van Creveld, pioneer of hemophilia care and coagulation research in the Netherlands: A personal account. J Thromb Haemost 2004; 2: 1029-33.
2. Bowie EJW, Owen CA, Thompson JH, Didisheim P. Platelet adhesiveness in von Willebrand's disease. Am J Physiol 1969; 52: 69-77.
3. Nilsson IM, Blombäck M, Jorpes E, Blomb̈ck B, Johansson SA. Von Willebrand's disease and its correction with human plasma fraction I-O. Acta Med Scand 1957; 159: 179-88.
4. Biggs R, Matthews JM. The treatment of haemorrhage in von Willebrand's disease and the blood level of factor VIII (AHG). Br J Haematol 1963; 9: 203-14.
5. Cornu P, Larrieu MJ, Caen J, Bernard J. Transfusion studies in von Willebrand's disease: Effect on bleeding time and factor VIII. Br J Haematol 1963; 9: 189-202.
6. Perkins HA. Correction of the haemostatic defects in von Willebrand's disease. Blood 1967; 30: 375-80.
7. Chan JYS, Owen CA, Bowie EJW, Didisheim P, Thompson JH, Muhrer ME, Zollman PE. Von Willebrand's disease stimulating factor in porcine plasma. Am J Physiol 1968; 214: 1219-24.
8. Zucker MB. In vitro abnormality of the blood in von Willebrand's disease correctable by normal plasma. Nature 1963; 197: 601-2.
9. Salzman EW, Britten A. In vitro correction of defective platelet adhesiveness in von Willebrand's disease. Fed Proc 1964; 23: 239 (Abstract).
10. Meyer DM, Larrieu MJ. Von Willebrand factor and platelet adhesiveness. J Clin Path 1970; 23: 228-31.
11. Hellem AJ. Platelet adhesiveness in von Willebrand's disease. A study with a new modification of the glass bead filter method. Scand J Haematol 1970; 7: 374-82.
12. Salzman EW. Measurement of platelet adhesiveness. A simple in vitro technique demonstrating an abnormality in von Willebrand's disease. J Lab Clin Med 1963; 62: 724-35.
13. Van Mourik JA, Mochtar IA. Purification of human antihemophilicfactor (factor VIII) by gelchromatography. Biochim Biophys Acta 1970; 221: 677-9.
14. Zimmerman TS, Ratnoff OD, Powell AE. Immunologic differentiation of classic hemophilia (factor VIII deficiency) and von Willebrand's disease. J Clin Invest 1971; 50: 244-54.
15. Bouma BN, Wiegerinck Y, Sixma JJ, van Mourik JA, Mochtar IA. Immunological characterization of purified Anti-Haemophilc Factor A (Factor VIII) which corrects abnormal platelet retention in von Willebrand's disease. Nature New Biol 1972; 236: 104-6.
16. Weiss HJ, Rogers J. Correction of the platelet abnormality in von Willebrand's disease by cryoprecipitate. Am J Med 1972; 53: 734-38.
17. Weiss HJ, Rogers J, Brand H. Properties of the platelet retention (von Willebrand) factor and its similarity to the Antihemophilic Factor (AHF). Blood 1973; 41: 809-15.
18. Howard MA, Firkin BG. Ristocetin -a new tool in the investigation of platelet aggregation. Thromb Diath Haemorrh 1971; 26: 362-9.
19. Meyer D, Jenkins CSP, Dreyfus M, Larrieu MJ. Experimental model for von Willebrand's disease. Nature 1973; 243: 293-4.
20. Weiss HJ, Rogers J, Brand H. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII. J Clin Invest 1973; 52: 2697-707.
21. Weiss HJ, Hoyer LW, Rickles FR, Varma A, Rogers J. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. J Clin Invest 1973; 52: 2708-16.
22. Laurell CB. Quantitative estimation of proteins by electropheresis in agarose gel containing antibodies. Anal Biochem 1966; 15: 45-52.
23. Meyer D, Lavergne JM, Larrieu MJ, Josso F. Cross-reacting material in congenital factor VIII deficiencies (Haemophilia A and von Willebrand's disease). Thromb Res 1972; 1: 183-96.
24. Bouma BN, Sixma JJ, de Graaf S, Wiegerinck Y, van Mourik JA, Mochtar IA. Factor-VIII antigen and platelet retention in a glass bead column. Br J Haematol 1973; 25: 645-56.
25. Holmberg L, Nilsson IM. Genetic variants of von Willebrand's disease. Br Med J 1972; 3: 317-20.
26. Jongkind JF, Wisse JH, Bloemendaal H. The effects of cross-linking on polyacrylamide gel electrophoresis of α-crystallin. In: Peeters H, ed. Protides of the Biological Fluids, 10th Colloqium. Oxford: Pergamon Press, 1962: 77.
27. Ugel AR, Chrambach A, Rodbard D. Fractionation and characterization of an oligomeric series of bovine keratohyalin by polyacrylamide gel electrophoresis. Anal Biochem 1971; 43: 410-26.
28. Hjertén S, Jerstedt S, Tiselius A. Some aspects of the use of 'continuous' and 'discontinuous' buffer systems in polyacrylamide gel electrophoresis. Anal Biochem 1965; 11: 219-23.
29. Van Mourik JA, Bouma BN, LaBruyere WT, de Graaf S, Mochtar IA. Factor VIII, a series of homologous oligomers and a complex of two proteins. Thromb Res 1974; 4: 155-64.
30. Bennett B, Ratnoff OD, Levin J. Immunologic studies in von Willebrand's disease. Evidence that the hemophilic factor (AHF) produced after transfusions lacks an antigen associated with normal AHF and the inactive material produced by patients with classis hemophilia. J Clin Invest 1972; 51: 2597-601.
31. Bloom AL, Peake IR, Giddings JC. The presence and reactions of high and low-molecular weight procoagulant factor VIII in the plasma of patients with von Willebrand's disease after treatment: Significance for a structural hypothesis for factor VIII. Thromb Res 1973; 3: 389-404.
32. Weiss HJ, Kochwa S. Molecular forms of antihemophilic globulin in plasma, cryoprecipitate and after thrombin activation. Br J Haematol 1970; 18: 89-100.
33. Owen WG, Wagner RH. Antihemophilic factor separation of an active fragment following dissociation by salts or detergents. Thromb Diath Haemorrh 1972; 27: 502-15.
34. 2. Proc Natl Acad Sci USA 1973; 70: 2326-9.
35. Weiss HJ, Hoyer LW. Von Willebrand factor: Dissociation from anti-hemophilic factor procoagulant activity. Science 1973; 182: 1149-51.
36. Rick ME, Hoyer LW. Immunologic studies of antihemophilic factor (AHF, factor VIII). V. Immunologic properties of AHF subunits produced by salt dissociation. Blood 1973; 42: 737-47.
37. Zimmerman TS, Edgington TS. Factor VIII coagulant activity and factor VIII-like antigen: Independent molecular entities. J Exp Med 1973; 138: 1015-20.
38. Owen WG. Big piece, little piece or: Yes, factor VIII is a protein. J Thromb Haemost 2005; 3: 1905-9.
39. Bouma BN, Dodds WJ, van Mourik JA, Sixma JJ, Webster WP. Infusion of human and canine factor VIII in dogs with von Willebrand's disease: studies of the von Willebrand and factor VIII stimulating factors. Scand J Haematol 1976; 17: 263-75.
40. Furlan M. Proteolytic cleavage of von Willebrand factor by ADAMTS-13 prevents uninvited clumping of blood platelets. J Thromb Haemost 2004; 2: 1505-14.
41. Bouma BN, van Mourik JA. The biochemistry of factors VIII and IX. In: Ogston D, Bennett B, eds. Haemostasis: Biochemistry, Physiology, and Pathology. London: John Wiley & Sons, 1977: 56-77.
42. Bouma BN, van Mourik JA, de Graaf S, Hordijk-Hos JM, Sixma JJ. Immunologic studies on Human Factor VIII (Anti-Hemophilic Factor A, AHF) components produced by low-ionic-strength dialysis. Blood 1976; 47: 253-64.